维力医疗
(603309)
| 流通市值：33.74亿 | | | 总市值：33.74亿 |
| 流通股本：2.92亿 | | | 总股本：2.92亿 |
| 利润表 |
| 报告期 | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 |
| 营业总收入 | 768,844,324.28 | 356,975,553.03 | 1,631,174,995.72 | 1,191,172,720.75 |
| 营业总成本 | 645,190,097.23 | 288,079,414.9 | 1,358,927,688.58 | 966,698,297.98 |
| 其他经营收益 | | | | |
| 营业利润 | 128,694,062.66 | 73,115,656.5 | 130,470,992.1 | 235,034,616.64 |
| 利润总额 | 128,063,471.7 | 73,117,207.44 | 130,280,382.26 | 234,925,394.34 |
| 净利润 | 107,984,172.05 | 61,891,380.26 | 87,125,117.77 | 199,795,174.69 |
| 每股收益 | | | | |
| 其他综合收益 | 235,835.41 | -957,104.01 | 4,577,794.73 | 4,481,304.95 |
| 综合收益总额 | 108,220,007.46 | 60,934,276.24 | 91,702,912.5 | 204,276,479.64 |
| 资产负债表 |
| 报告期 | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 |
| 流动资产: | | | | |
| 流动资产合计 | 856,428,547.45 | 868,837,374.64 | 967,187,595.79 | 903,471,348.02 |
| 非流动资产: | | | | |
| 非流动资产合计 | 1,868,739,601.38 | 1,882,745,148.8 | 1,893,245,250.1 | 2,004,271,728.34 |
| 资产总计 | 2,725,168,148.83 | 2,751,582,523.44 | 2,860,432,845.89 | 2,907,743,076.36 |
| 流动负债: | | | | |
| 流动负债合计 | 493,532,385.87 | 474,724,240.13 | 637,650,429 | 509,033,099.97 |
| 非流动负债: | | | | |
| 非流动负债合计 | 440,819,668.32 | 437,066,494.49 | 446,242,331.03 | 451,499,789.48 |
| 负债合计 | 934,352,054.19 | 911,790,734.62 | 1,083,892,760.03 | 960,532,889.45 |
| 所有者权益(或股东权益): | | | | |
| 归属于母公司股东权益合计 | 1,778,666,691.69 | 1,823,040,841.11 | 1,761,687,119.58 | 1,935,284,631.87 |
| 股东权益合计 | 1,790,816,094.64 | 1,839,791,788.82 | 1,776,540,085.86 | 1,947,210,186.91 |
| 负债和股东权益合计 | 2,725,168,148.83 | 2,751,582,523.44 | 2,860,432,845.89 | 2,907,743,076.36 |
| 现金流量表 |
| 报告期 | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 |
| 经营活动产生的现金流量: | | | | |
| 经营活动现金流入小计 | 874,738,341 | 429,141,879.94 | 1,753,203,903.64 | 1,265,849,780.06 |
| 经营活动现金流出小计 | 714,505,351.76 | 360,873,525.93 | 1,422,948,694.27 | 1,105,732,901.3 |
| 经营活动产生的现金流量净额 | 160,232,989.24 | 68,268,354.01 | 330,255,209.37 | 160,116,878.76 |
| 投资活动产生的现金流量: | | | | |
| 投资活动现金流入小计 | 512,628,866.11 | 198,091,008.78 | 488,071,882.81 | 476,987,281.65 |
| 投资活动现金流出小计 | 458,590,623.49 | 172,086,102.53 | 737,645,129.5 | 537,124,500.99 |
| 投资活动产生的现金流量净额 | 54,038,242.62 | 26,004,906.25 | -249,573,246.69 | -60,137,219.34 |
| 筹资活动产生的现金流量: | | | | |
| 筹资活动现金流入小计 | 187,000,000 | 17,263,527.55 | 209,384,592.4 | 209,384,592.4 |
| 筹资活动现金流出小计 | 350,178,011.55 | 74,782,633.18 | 335,738,089.32 | 309,288,217.79 |
| 筹资活动产生的现金流量净额 | -163,178,011.55 | -57,519,105.63 | -126,353,496.92 | -99,903,625.39 |
| 汇率变动对现金及现金等价物的影响 | -2,786,384.71 | -1,495,982.16 | -2,805,119.64 | -1,523,011.64 |
| 现金及现金等价物净增加额 | 48,306,835.6 | 35,258,172.47 | -48,476,653.88 | -1,446,977.61 |
| 期末现金及现金等价物余额 | 287,466,112.8 | 274,417,449.67 | 239,159,277.2 | 286,188,953.47 |
| 补充资料: | | | | |
| 现金及现金等价物的净增加额 | 48,306,835.6 | - | -48,476,653.88 | - |
最新报告期：2026-05-28| 研究机构 | 分析师 | 预测每股收益(元) | 更新日 |
| 2026年 | 2027年 | 2028年 |
| 华创证券 | 郑辰,李婵娟 | 0.92 | 1.09 | 1.31 | 2026-05-28 |
| 华创证券 | 郑辰,李婵娟 | 0.92 | 1.09 | 1.31 | 2026-05-26 |